glp-1 weight loss clinical trials GLP1 agonists: current and future landscape of for patients with metabolic dysfunction Who is a Good Candidate

Until recently, the most effective new obesity medications, including semaglutide (Wegovy) and tirzepatide (Zepbound), were available only as injectables

May administer without regard to food Kidney disease No dose adjustment is necessary for any degree of renal impairment Liver disease No dose adjustment is necessary for any degree of hepatic impairment Generic / Price NO/$$$$ Storage Unused pens Keep refrigerated Good until expiration date Do not freeze After first dose Store at room temperature or refrigerated Good for 56 days Semaglutide Rybelsus Rybelsus Dosage forms Tablet (formulation R1) 3 mg 7 mg 14 mg Tablet (formulation R2) 1.5 mg 4 mg 9 mg Dosing Type 2 diabetes (formulation R1) Starting (Day 1 to 30): 3 mg once daily for 30 days (this dosage is not effective for glycemic control) Escalation and Maintenance Dosage: Days 31 to 60: Increase the dosage to 7 mg orally once daily Day 61 and on: If blood sugars are controlled, continue 7 mg once daily

Pharmacy Accreditation : Does the provider partner with 503A or 503B regulated compounding pharmacies

GLP-1s may boost female fertility